Visteon (VC) Downgraded by Morgan Stanley

Morgan Stanley cut shares of Visteon (NYSE:VC) from an overweight rating to an underweight rating in a research report released on Thursday morning, Marketbeat.com reports. They currently have $110.00 target price on the auto parts company’s stock.

A number of other brokerages have also recently commented on VC. Zacks Investment Research raised Visteon from a hold rating to a buy rating and set a $141.00 price target for the company in a research note on Saturday, January 6th. Royal Bank of Canada lowered their price target on Visteon to $131.00 and set a sector perform rating for the company in a research note on Sunday, January 21st. Guggenheim reaffirmed a buy rating and issued a $154.00 price target on shares of Visteon in a research note on Wednesday, January 10th. Gabelli raised Visteon from a hold rating to a buy rating and set a $158.00 price target for the company in a research note on Monday, February 26th. Finally, ValuEngine raised Visteon from a hold rating to a buy rating in a research note on Sunday, December 31st. Two analysts have rated the stock with a sell rating, six have given a hold rating and twelve have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $137.33.

How to Become a New Pot Stock Millionaire

Shares of Visteon stock opened at $108.76 on Thursday. The firm has a market capitalization of $3,770.00, a PE ratio of 8.62, a price-to-earnings-growth ratio of 1.34 and a beta of 0.88. Visteon has a twelve month low of $91.20 and a twelve month high of $140.64. The company has a current ratio of 1.97, a quick ratio of 1.76 and a debt-to-equity ratio of 0.47.

Visteon (NYSE:VC) last announced its quarterly earnings data on Thursday, February 22nd. The auto parts company reported $1.64 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.73 by ($0.09). The firm had revenue of $797.00 million for the quarter, compared to the consensus estimate of $797.55 million. Visteon had a return on equity of 29.13% and a net margin of 4.83%. The business’s revenue for the quarter was down 2.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.55 earnings per share. equities analysts anticipate that Visteon will post 6.23 earnings per share for the current fiscal year.

Visteon declared that its Board of Directors has initiated a stock buyback plan on Tuesday, January 16th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the auto parts company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

In related news, CEO Sachin Lawande sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $130.00, for a total value of $325,000.00. Following the completion of the transaction, the chief executive officer now directly owns 8,595 shares in the company, valued at approximately $1,117,350. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 11,539 shares of company stock valued at $1,474,051 over the last quarter. 0.19% of the stock is owned by insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. The Manufacturers Life Insurance Company grew its position in shares of Visteon by 6.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,040 shares of the auto parts company’s stock valued at $106,000 after purchasing an additional 61 shares during the period. BNP Paribas Arbitrage SA grew its position in shares of Visteon by 32.3% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 1,773 shares of the auto parts company’s stock valued at $219,000 after purchasing an additional 433 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Visteon by 42.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,758 shares of the auto parts company’s stock valued at $220,000 after purchasing an additional 526 shares during the period. State of Alaska Department of Revenue acquired a new position in shares of Visteon in the 4th quarter valued at approximately $287,000. Finally, Ladenburg Thalmann Financial Services Inc. boosted its position in Visteon by 644.8% during the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,294 shares of the auto parts company’s stock worth $287,000 after acquiring an additional 1,986 shares during the last quarter.

COPYRIGHT VIOLATION NOTICE: “Visteon (VC) Downgraded by Morgan Stanley” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3300990/visteon-vc-downgraded-by-morgan-stanley.html.

About Visteon

Visteon Corporation is a global automotive supplier that designs, engineers and manufactures electronics products for original equipment vehicle manufacturer (OEM), including Ford, Mazda, Nissan/Renault, General Motors, Honda BMW and Daimler. The Company operates through Electronics segment. The Electronics segment provides vehicle cockpit electronics products to customers, including instrument clusters, information displays, infotainment, audio systems, telematics solutions and head up displays.

Analyst Recommendations for Visteon (NYSE:VC)

Receive News & Ratings for Visteon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Visteon and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cara Therapeutics  Receives $25.18 Consensus Target Price from Analysts
Cara Therapeutics Receives $25.18 Consensus Target Price from Analysts
Brokerages Set Tallgrass Energy Partners LP  Price Target at $48.67
Brokerages Set Tallgrass Energy Partners LP Price Target at $48.67
Amarin Co.  Expected to Post Earnings of -$0.07 Per Share
Amarin Co. Expected to Post Earnings of -$0.07 Per Share
Etheroll  Trading Up 58.5% Over Last 7 Days
Etheroll Trading Up 58.5% Over Last 7 Days
Contrasting TransMontaigne  & Shell Midstream Partners
Contrasting TransMontaigne & Shell Midstream Partners
Analyzing Superior Uniform Group  & Lululemon Athletica
Analyzing Superior Uniform Group & Lululemon Athletica


© 2006-2018 Ticker Report. Google+.